UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

International journal of radiation oncology, biology, physics, 2013-03, Vol.85 (3), p.672-678

2013

Volltextzugriff (PDF)

A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients

BMC urology, 2011-07, Vol.11 (1), p.15-15, Article 15

Tunn, Ulf W

2011

Volltextzugriff (PDF)

Prognostic Value of Combined “Triple”-Reverse Transcription-PCR Analysis for Prostate-Specific Antigen, Human Kallikrein 2, and Prostate-Specific Membrane Antigen mRNA in Peripheral Blood and Lymph Nodes of Prostate Cancer Patients

Clinical cancer research, 2004-09, Vol.10 (17), p.5808-5814

2004

Volltextzugriff (PDF)

High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients

Radiation oncology (London, England), 2013-05, Vol.8 (1), p.115-115, Article 115

2013

Volltextzugriff (PDF)

Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy

Research and reports in urology, 2016-01, Vol.8, p.133-143

2016

Volltextzugriff (PDF)

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation

Clinical interventions in aging, 2013-01, Vol.8, p.457-464

2013

Volltextzugriff (PDF)

Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases

Canadian journal of urology, 2012-06, Vol.19 (3), p.6261

2012

Volltextzugriff (PDF)

Efficacy and tolerability of 3- and 6-month depot formulations of leuprorelin acetate for advanced prostate cancer in treatment-naïve and pretreated patients: pooled data from two non-interventional studies

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e16098-e16098

2015

Volltextzugriff (PDF)

Are PSA baseline levels an indicator for suitability of intermittent androgen deprivation in patients with PSA relapse after radical prostatectomy?

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.136-136

2013

Volltextzugriff (PDF)

Quantitative PSA RT-PCR for preoperative staging of prostate cancer

The Prostate, 2003-09, Vol.56 (4), p.263-269

2003

Volltextzugriff (PDF)

Human kallikrein 2 (hk2) mRNA in peripheral blood of patients with thyroid cancer: A novel molecular marker?

Journal of cancer research and clinical oncology, 2003, Vol.129 (1), p.29-34

2003

Volltextzugriff (PDF)

Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread

Urolithiasis, 1999-02, Vol.27 (1), p.23-27

1999

Volltextzugriff (PDF)

600: Intermittent Androgen Deprivation in Patients with PSA-Relapse after Radical Prostatectomy - Final Results of a European Randomized Prospective Phase-III Clinical Trial Auo Study AP 06/95, EC 507

The Journal of urology, 2007-04, Vol.177 (4), p.201-201

2007

Volltextzugriff (PDF)

973: HDR Brachytherapy as a Boost for Intermediate and High Risk Prostate Cancer: Longterm Outcome of 2028 Implants

The Journal of urology, 2006-04, Vol.175 (4), p.314-314

2006

Volltextzugriff (PDF)

Transdifferentiation of distal but not proximal tubular epithelial cells from human kidney in culture

Experimental nephrology, 1999-07, Vol.7 (4), p.306-313

1999

Volltextzugriff (PDF)

Sepsis associated with urinary tract infection. Antibiotic treatment with piperacillin

Archives of internal medicine (1960), 1982-10, Vol.142 (11), p.2035

1982

Volltextzugriff (PDF)

Effects of androgen deprivation prior to radical prostatectomy in 375 patients

Urologia internationalis, 1996, Vol.56 Suppl 1 (1), p.6-12

1996

Volltextzugriff (PDF)

Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia

Steroids, 1987-07, Vol.50 (1), p.191-200

1987

Volltextzugriff (PDF)

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Journal of clinical oncology, 2015-07, Vol.33 (20), p.2279-2287

2015

Volltextzugriff (PDF)

The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma

European journal of cancer (1990), 2020-01, Vol.125, p.130-141

2020

Volltextzugriff (PDF)

The role of intra-operative pathological evaluation in the management of musculoskeletal tumours

Recent results in cancer research, 2009, Vol.179, p.11

2009

Volltextzugriff (PDF)

Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities

Recent results in cancer research, 2009, Vol.179, p.257

2009

Volltextzugriff (PDF)

Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer

BJU international, 2006-07, Vol.98 (1), p.20-27

2006

Volltextzugriff (PDF)

Diagnostik von Knochenmetastasen heute und morgen

Osteologie, 2014, Vol.23 (4), p.245-249

2014

Volltextzugriff (PDF)

Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Long-term Results of a European Organization for Research and Treatment of Cancer Randomized Trial Comparing Doxorubicin, Ethoglucid and Transurethral Resection Alone

The Journal of urology, 1997-08, Vol.158 (2), p.378-384

1997

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(26)
Buchkapitel
(1)

Sprache

Englisch
(26)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Male
(17)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Middle Aged
(9)
Urology & Nephrology
(9)
Aged
(8)
Adult
(7)
Aged, 80 And Over
(7)
Prostate Cancer
(7)
Female
(6)
Oncology
(6)
Biological And Medical Sciences
(5)
Medical Sciences
(4)
Neoplasm Staging
(4)
Prostatic Neoplasms - Drug Therapy
(4)
Prostatic Neoplasms - Pathology
(4)
Reverse Transcriptase Polymerase Chain Reaction
(4)
Time Factors
(4)
Antineoplastic Agents, Hormonal - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients

Prognostic Value of Combined “Triple”-Reverse Transcription-PCR Analysis for Prostate-Specific Antigen, Human Kallikrein 2, and Prostate-Specific Membrane Antigen mRNA in Peripheral Blood and Lymph Nodes of Prostate Cancer Patients

High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients

Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation

Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases

Efficacy and tolerability of 3- and 6-month depot formulations of leuprorelin acetate for advanced prostate cancer in treatment-naïve and pretreated patients: pooled data from two non-interventional studies

Are PSA baseline levels an indicator for suitability of intermittent androgen deprivation in patients with PSA relapse after radical prostatectomy?

Quantitative PSA RT-PCR for preoperative staging of prostate cancer

Human kallikrein 2 (hk2) mRNA in peripheral blood of patients with thyroid cancer: A novel molecular marker?

Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread

600: Intermittent Androgen Deprivation in Patients with PSA-Relapse after Radical Prostatectomy - Final Results of a European Randomized Prospective Phase-III Clinical Trial Auo Study AP 06/95, EC 507

973: HDR Brachytherapy as a Boost for Intermediate and High Risk Prostate Cancer: Longterm Outcome of 2028 Implants

Transdifferentiation of distal but not proximal tubular epithelial cells from human kidney in culture

Sepsis associated with urinary tract infection. Antibiotic treatment with piperacillin

Effects of androgen deprivation prior to radical prostatectomy in 375 patients

Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma

The role of intra-operative pathological evaluation in the management of musculoskeletal tumours

Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities

Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer

Diagnostik von Knochenmetastasen heute und morgen

Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Long-term Results of a European Organization for Research and Treatment of Cancer Randomized Trial Comparing Doxorubicin, Ethoglucid and Transurethral Resection Alone

Suchergebnisse filtern